Elaine Chen
@elaineywchen.bsky.social
Reporter @statnews.com covering drugs and the biopharma industry | signal: elaineywchen.70
Novo also invested much less in R&D than competitor Eli Lilly
It tended to advance one candidate at a time, rather than simultaneously advance multiple candidates at once to see what stuck, one former employee said
www.statnews.com/2025/06/05/n...
It tended to advance one candidate at a time, rather than simultaneously advance multiple candidates at once to see what stuck, one former employee said
www.statnews.com/2025/06/05/n...
June 5, 2025 at 4:13 PM
Novo also invested much less in R&D than competitor Eli Lilly
It tended to advance one candidate at a time, rather than simultaneously advance multiple candidates at once to see what stuck, one former employee said
www.statnews.com/2025/06/05/n...
It tended to advance one candidate at a time, rather than simultaneously advance multiple candidates at once to see what stuck, one former employee said
www.statnews.com/2025/06/05/n...
Pfizer also replaced language saying that it partners with groups that “are dedicated to championing historically underrepresented populations” and deleted a list of its partners
www.statnews.com/2025/02/27/p...
www.statnews.com/2025/02/27/p...
February 28, 2025 at 2:08 PM
Pfizer also replaced language saying that it partners with groups that “are dedicated to championing historically underrepresented populations” and deleted a list of its partners
www.statnews.com/2025/02/27/p...
www.statnews.com/2025/02/27/p...
Pfizer yesterday revised its DEI webpage to emphasize the importance of "merit," joining other companies seeking to align with the Trump administration
@jaspar.bsky.social and I laid out all the deletions and insertions in our story
www.statnews.com/2025/02/27/p...
@jaspar.bsky.social and I laid out all the deletions and insertions in our story
www.statnews.com/2025/02/27/p...
February 28, 2025 at 2:08 PM
Pfizer yesterday revised its DEI webpage to emphasize the importance of "merit," joining other companies seeking to align with the Trump administration
@jaspar.bsky.social and I laid out all the deletions and insertions in our story
www.statnews.com/2025/02/27/p...
@jaspar.bsky.social and I laid out all the deletions and insertions in our story
www.statnews.com/2025/02/27/p...
Insurers and employers are in a difficult position, given how costly the medications are. Plans' spending on diabetes and weight loss drugs have quickly shifted toward the new GLP-1s:
August 3, 2023 at 2:10 PM
Insurers and employers are in a difficult position, given how costly the medications are. Plans' spending on diabetes and weight loss drugs have quickly shifted toward the new GLP-1s: